|
1
|
Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6.
|
Cerebellum
|
2010
|
1.69
|
|
2
|
Reliability and validity of the scale for the assessment and rating of ataxia: a study in 64 ataxia patients.
|
Mov Disord
|
2007
|
1.58
|
|
3
|
Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients.
|
Mov Disord
|
2005
|
1.54
|
|
4
|
Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
|
Neuroimage
|
2009
|
1.29
|
|
5
|
Comparison of three clinical rating scales in Friedreich ataxia (FRDA).
|
Mov Disord
|
2009
|
1.04
|
|
6
|
Falls in spinocerebellar ataxias: Results of the EuroSCA Fall Study.
|
Cerebellum
|
2010
|
0.98
|
|
7
|
Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings.
|
Cerebellum
|
2012
|
0.93
|
|
8
|
Spinocerebellar ataxia type 11 (SCA11) is an uncommon cause of dominant ataxia among French and German kindreds.
|
J Neurol Neurosurg Psychiatry
|
2010
|
0.90
|
|
9
|
Bright light therapy in Parkinson's disease: a pilot study.
|
Mov Disord
|
2007
|
0.89
|
|
10
|
Spinocerebellar ataxia type 15: diagnostic assessment, frequency, and phenotypic features.
|
J Med Genet
|
2011
|
0.86
|
|
11
|
Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency.
|
J Neurol
|
2015
|
0.76
|